CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Mallinckrodt IP v. B. Braun Medical Inc.

1:17-cv-00660

Overview

Case Number 1:17-cv-00660
Filing Date 2017-05-31
Status Terminated
Termination Date 2018-10-05
Court District Court, D. Delaware (ded)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action no cause specified
Jury Demand None

Parties

Defendant

B. Braun Medical Inc. Operating Company

Represented By

3 Attorneys Listed

Gregory Erich Stuhlman

Chipman Brown Cicero & Cole, LLP

Tel: +1 (302) 468-4597

Hercules Plaza, 1313 N. Market Street

Benjamin J. Schladweiler

Greenberg Traurig, LLP

Tel: +1 (302) 661-7394

The Nemours Building, 1007 North Orange Street, Suite 1200

Steven T. Margolin

Greenberg Traurig, LLP

Tel: +1 (302) 661-7376

The Nemours Building, 1007 North Orange Street, Suite 1200

Plaintiff

Mallinckrodt IP Unlimited Company NPE (University / Research)

Represented By

3 Attorneys Listed

Stephen J. Kraftschik

Polsinelli PC

Tel: +1 (302) 252-0926
Fax: +1 (302) 252-0921

222 Delaware Avenue, Suite 1101, Wilmington, DE 19801

Jeremy A. Tigan

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 351-9106

1201 North Market Street, P.O. Box 1347

Thomas C. Grimm

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Mallinckrodt Hospital Products Inc. Operating Company

Represented By

3 Attorneys Listed

Stephen J. Kraftschik

Polsinelli PC

Tel: +1 (302) 252-0926
Fax: +1 (302) 252-0921

222 Delaware Avenue, Suite 1101, Wilmington, DE 19801

Jeremy A. Tigan

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 351-9106

1201 North Market Street, P.O. Box 1347

Thomas C. Grimm

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Mallinckrodt IP NPE (Individual / Inventor)

Represented By

3 Attorneys Listed

Stephen J. Kraftschik

Polsinelli PC

Tel: +1 (302) 252-0926
Fax: +1 (302) 252-0921

222 Delaware Avenue, Suite 1101, Wilmington, DE 19801

Jeremy A. Tigan

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 351-9106

1201 North Market Street, P.O. Box 1347

Thomas C. Grimm

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Court & Judges

Court

District Court, D. Delaware (ded)

Global Patent Family Cross-Litigation Radar

CasLoc 360Β° Radar 5 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

πŸ‡ΊπŸ‡Έ
U.S. District Courts 1 proceeding
πŸ›οΈ
USPTO PTAB Trials Counterparts in force
πŸ‡ͺπŸ‡Ί
Unified Patent Court (UPC) Counterparts in force
πŸ‡©πŸ‡ͺ
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (5): πŸ‡ΊπŸ‡Έ US
Parallel Proceedings Across Jurisdictions (1 found):
U.S. Courts: 1
U.S. District Court 2018-07-24
1:18-cv-01090

Mallinckrodt Hospital Products IP Ltd. v. B. Braun Medical Inc.

U.S. Family Sibling (["US9987238"])
Status: DED
Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

2 Patents

There are 2 patents involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US9399012
Reduced dose intravenous acetaminophen
Filed: 2008-11-13
Issued: 2016-07-26
Active (4.8 yrs remaining) +1032d PTA
Expires: 2031-09-11
US9610265
Reduced dose intravenous acetaminophen
Filed: 2016-06-16
Issued: 2017-04-04
Active (9.6 yrs remaining)
Expires: 2036-06-16

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. Β§ 283) Active Threat

Active Threat β€” Patent is within enforceable statutory term; injunctive relief viable.

Terminal Disclaimer & Cellect Risk Scrutiny / Risk

High PTA (+1032 days) / In re Cellect scrutiny applies.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. Β§ 286, damages cannot accrue for infringement prior to 6 years before filing. 4th & 8th Year Maintenance Fees Paid (12th Year Window Upcoming).

Procedural Motions & Interlocutory Orders

Motion Intelligence

Total Motions

4

Dispositive

4

Granted

0

Denied

0

Pending / Review

4

Motions by Category

Motion to Dismiss 4

Key Dispositive Motions & Rulings

Motion to Dismiss Pending / Under Review
ANSWERING BRIEF in Opposition re 13 MOTION to Dismiss for Improper Venue and for Fees Pursuant to 35 U.S.C. Section 285 filed by Mallinckrodt Hospital Products ...
Entry #17 • 2017-08-10 Document →
Motion to Dismiss Pending / Under Review
MOTION to Dismiss for Improper Venue and for Fees Pursuant to 35 U.S.C. Section 285 - filed by B. Braun Medical Inc.. (Stuhlman, Gregory) (Entered: 07/31/2017)
Entry #13 • 2017-07-31 Document →
Motion to Dismiss Pending / Under Review
DECLARATION re 13 MOTION to Dismiss for Improper Venue and for Fees Pursuant to 35 U.S.C. Section 285 of Cathy Codrea, Esq. by B. Braun Medical Inc.. (Stuhlman,...
Entry #14 • 2017-07-31 Document →
Motion to Dismiss Pending / Under Review
MOTION to Dismiss for Improper Venue Defendant B. Braun Medical Inc.'s Motion to Dismiss - filed by B. Braun Medical Inc.. (Attachments: # 1 Exhibit A - First P...
Entry #8 • 2017-07-06 Document →

Docket Entries

(21 total)
Pleading / Complaint

COMPLAINT FOR PATENT INFRINGEMENT filed against B. Braun Medical Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2152655.) - filed by Mallinckrodt IP, Mallinckrodt Hospital Products Inc.. (Attachments: # 1 Exhibit A-C, # 2 Civil Cover Sheet)(jcs) (Entered: 06/01/2017)

Entry #1 • 2017-05-31
1

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (jcs) (Entered: 06/01/2017)

Entry #2 • 2017-05-31
1

Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: See Attached. Date of Expiration of Patent: See Attached.Thirty Month Stay Deadline: See Attached. (jcs) (Entered: 06/01/2017)

Entry #3 • 2017-05-31
1

Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Mallinckrodt plc. for Mallinckrodt Hospital Products Inc. filed by Mallinckrodt Hospital Products Inc.. (jcs) (Entered: 06/01/2017)

Entry #4 • 2017-05-31
1

Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Mallinckrodt plc. for Mallinckrodt IP filed by Mallinckrodt IP. (jcs) (Entered: 06/01/2017)

Entry #5 • 2017-05-31
1

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc